TerminatedNot applicableNCT02673021

MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)

Does lung ablation improve clinical outcomes for patients deemed to be surgically high-risk?

Checked against the public recordLast updated Oct 4, 2023 · Source: ClinicalTrials.gov

StatusTerminated
PhaseNot applicable
U.S. locations2
SponsorMayo Clinic
01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Not applicable
Sponsor
Mayo Clinic
Interventions being studied
Procedure: Microwave ablation
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
03
Public criteria

Who may be able to participate

Inclusion Criteria: * Subject must be at least 18 years old. * Subject is able to understand the study procedures and provide informed consent. * Subject is willing and able to complete the entire study as specified in the protocol, including the follow-up visits. * Subject has lung lesion that is biopsy-proven cancer (of any type) or suspicious, with confirmation at the time of the procedure. * Lung lesion(s) are reachable/treatable per clinician opinion. * Subject can have other location of disease if it is controlled, or there are plans for control. * Subject has 1 or more lung nodules (not more than 10), that have a mean diameter \<3 cm on axial CT scan. * Life expectancy ≥6 months Exclusion Criteria: * Subject is pregnant or breast feeding. * Subject has a significant clinical disease or condition, e.g. cardiovascular, respiratory, gastrointestinal, renal, hepatic, hematological, psychiatric or neurologic that would preclude enrollment, as determined by the primary investigator. * Subject has another location of disease that is not controlled, and there are no plans for control. * Subject has more than 10 lung nodules.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Mayo ClinicRochester, Minnesota
  • Mayo Clinic in RochesterRochester, Minnesota

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 4, 2023. Always confirm current availability with the study team.

View original record ↗